Thomas J. Herzfeld Advisors, Inc. Dr Reddys Laboratories LTD Transaction History

Thomas J. Herzfeld Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$61.9 - $72.77 $1,052 - $1,237	17 New	17 $1.14 Million
Q2 2023 Aug 14, 2023	SELL	$53.34 - $63.11 $1,173 - $1,388	-22 Reduced 56.41%	17 $1,000
Q1 2023 May 16, 2023	BUY	$51.63 - $56.93 $2,013 - $2,220	39 New	39 $2,000
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $1,428 - $1,614	-24 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$60.19 - $75.29 $1,324 - $1,656	-22 Reduced 47.83%	24 $2,000
Q1 2021 May 14, 2021	BUY	$57.98 - $73.08 $2,667 - $3,361	46 New	46 $3,000

233

24M

14.6K

2.8K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13.2B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Thomas J. Herzfeld Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Thomas J. Herzfeld Advisors, Inc. with notifications on news.